Related Experiment Video
Updated: Dec 5, 2025

Vessel-sparing Excision and Primary Anastomosis
Published on: January 7, 2019
Prostatic Artery Embolization Is Safe and Effective for Medically Recalcitrant Radiation-Induced Prostatitis
Nainesh Parikh1, Edward Keshishian1, Ayushman Sharma1
1Department of Diagnostic Imaging and Interventional Radiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.
Prostatic artery embolization (PAE) offers clinical improvement for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) after radiation therapy. This minimally invasive procedure shows promise for patients with refractory symptoms where medical treatments have failed.
Area of Science:
- Urology
- Interventional Radiology
- Oncology
Background:
- Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) affects many patients post-radiation therapy (RT) for prostate cancer.
- Medical therapies offer limited success, with approximately 50% efficacy and no consistent treatment for refractory cases.
- Prostatic artery embolization (PAE) is established for benign prostatic hyperplasia symptoms.
Purpose of the Study:
- To evaluate the clinical effectiveness of PAE in men with CP/CPPS following RT.
- To report outcomes in a case series of patients with radiation-induced CP/CPPS treated with PAE.
Main Methods:
- Nine male patients (median age 72) with CP/CPPS post-RT underwent PAE.
- Pre-procedure assessment included International Prostate Symptom Score, Chronic Prostatitis Symptom Index, and quality of life (QoL) scores.
- Follow-up at 6 and 12 weeks included symptom scores, QoL assessment, and MRI.
Main Results:
- Technical success (bilateral embolization) was achieved in 78% of patients; unilateral embolization in the remainder.
- No major complications were reported.
- Clinical success was observed in 89% of patients, with 78% reporting improved QoL.
Conclusions:
- CP/CPPS after RT is a debilitating condition with limited success from conventional medical therapy.
- PAE demonstrates potential as an effective treatment option for medically refractory CP/CPPS post-RT.
- Further research is needed to optimize patient selection and treatment protocols for PAE in this context.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Peripheral Artery Disease III: Interprofessional Care

